Goat Polyclonal NOX1 antibody. Suitable for WB and reacts with Human samples. Cited in 17 publications. Immunogen corresponding to Synthetic Peptide within Human NOX1 aa 450-550.
View Alternative Names
MOX1, NOH1, NOX1, NADPH oxidase 1, NOX-1, Mitogenic oxidase 1, NADH/NADPH mitogenic oxidase subunit P65-MOX, NOH-1, MOX-1
- WB
Supplier Data
Western blot - Anti-NOX1 antibody (AB121009)
Lysates in RIPA buffer. Detected by chemiluminescence.
All lanes:
Western blot - Anti-NOX1 antibody (ab121009) at 0.5 µg/mL
Lane 1:
CaCo-2 cell lysate at 35 µg
Lane 2:
CaCo-2 + peptide cell lysate at 35 µg
Lane 3:
HeLa cell lysate at 35 µg
Lane 4:
HeLa + peptide cell lysate at 35 µg
Lane 5:
A549 cell lysate at 35 µg
Lane 6:
A549 + peptide cell lysate at 35 µg
Lane 7:
U937 cell lysate at 35 µg
Lane 8:
U937 + peptide cell lysate at 35 µg
false
- WB
CiteAb
Western blot - Anti-NOX1 antibody (AB121009)
NOX1 western blot using anti-NOX1 antibody ab121009. Publication image and figure legend from De Bessa, T. C., Pagano, A., et al., 2019, Cell Death Dis, PubMed 30760703.
ab121009 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab121009 please see the product overview.
Nox NADPH oxidase expression and superoxide generation by HCT116 cells with overactivated KRas.a Nox1, NoxA1, p67phox, NoxO1, and p47phox basal protein expression by western analysis normalized for GADPH. Nox1 immunoblot densities were quantified using Odyssey software. *P < 0.05, ANOVA plus Tukey's multiple comparisons test (n = 3). b RhoGDIα, RhoA, and Rac1 basal protein expression by western analysis normalized for GAPDH. Rac1 immunoblot densities were quantified using Odyssey software. **P < 0.01; ***P < 0.005, ANOVA plus Tukey's multiple comparisons test (n = 3). c Nox1 complex scheme. d Rac1 basal activity, using Rac1 G-LISA activation assay (Cytoskeleton,inc). Test t *p < 0.05, (n = 2). e Rac1 protein expression by western analysis after 72 h of PDIA1 silencing. Rac1 Immunoblot densities were quantified using Odyssey software **P < 0.01; ns : not significant, Student's t-test (n = 3). f Western analysis of NoxO1 and RhoGDIα protein expression before and after PDIA1 silencing, normalized for GAPDH. RhoGDIα immunoblot densities were quantified using Odyssey software, ****P < 0.001; ns : not significant, Student's t-test (n = 3). g Superoxide production after 72h of PDIA1 silencing in HCT116 cells treated or not with 10 μM of NoxA1ds Nox1's peptide inhibitor. EOH 2-hidroxyethidiium relative superoxide production, si-PDI, si-RNA against PDIA1 protein; Scrmb NoxA1ds, NoxA1ds negative control peptide; NoxA1ds, Nox1 peptide inhibitor. *P < 0.05; **P < 0.01, ANOVA plus Tukey's multiple comparisons test (n = 3)
false
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
NOX1 is involved in cellular processes like host defense cellular signaling and regulation of gene expression. It is part of a multi-protein complex that includes p22phox NOXA1 and NOXO1 which are essential for its enzyme activity. NOX1 contributes to maintaining normal cell function through controlled production of ROS which act as signaling molecules that modulate various physiological processes. In the colon NOX1 plays a role in mucosal defense and epithelial cell proliferation.
Pathways
NOX1 is intimately involved in the redox regulation and signaling pathways. It participates in the MAPK signaling pathway that influences cell proliferation and differentiation. NOX1 also plays a role in the PI3K/AKT pathway which is linked to cell survival and apoptosis. Proteins such as Rac1 and p47phox are known to interact with NOX1 in these pathways influencing downstream signaling events important for maintaining cell homeostasis.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (17)
Recent publications for all applications. Explore the full list and refine your search
Cardiovascular therapeutics 2025:4506032 PubMed40313652
2025
Applications
Unspecified application
Species
Unspecified reactive species
Bioengineering (Basel, Switzerland) 11: PubMed38391611
2024
Applications
Unspecified application
Species
Unspecified reactive species
Chinese medicine 18:134 PubMed37833817
2023
Applications
Unspecified application
Species
Unspecified reactive species
Microvascular research 150:104590 PubMed37481160
2023
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 24: PubMed36902094
2023
Applications
Unspecified application
Species
Unspecified reactive species
Medicine 101:e30028 PubMed35960091
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of gastrointestinal oncology 13:754-767 PubMed35557596
2022
Applications
Unspecified application
Species
Unspecified reactive species
Bioengineered 12:10924-10934 PubMed34699317
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 12:723988 PubMed34658862
2021
Applications
Unspecified application
Species
Unspecified reactive species
Aging 13:22588-22610 PubMed34584017
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com